- Report
- April 2025
- 250 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- February 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- July 2024
- 100 Pages
Global
From €3413EUR$3,750USD£2,926GBP
- Report
- July 2020
- 156 Pages
Global
From €4505EUR$4,950USD£3,862GBP
- Report
- June 2022
- 112 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- February 2024
- 145 Pages
Global
From €3868EUR$4,250USD£3,316GBP
- Report
- August 2022
- 119 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- January 2025
- 80 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- January 2025
- 132 Pages
Global
From €865EUR$950USD£741GBP
The Automated Coagulation Instrument market within the Blood Banking industry is a rapidly growing sector. It is driven by the need for improved accuracy and efficiency in the testing of blood samples. Automated Coagulation Instruments are used to measure the clotting time of blood samples, which is essential for the diagnosis and treatment of various blood disorders. These instruments are also used to monitor the effectiveness of anticoagulant drugs. Automated Coagulation Instruments are designed to provide accurate and reliable results in a short amount of time.
The Automated Coagulation Instrument market is highly competitive, with a number of companies offering a wide range of products. Some of the major players in the market include Siemens Healthineers, Roche Diagnostics, Abbott Laboratories, Sysmex Corporation, and Beckman Coulter. Show Less Read more